PDS Biotechnology (PDSB) Proxy filing summary

Executive summary

• Annual meeting scheduled for August 10, 2026, with voting available online and virtually.

• Shareholders are encouraged to review proxy materials and vote by August 9, 2026, or August 5, 2026, for plan shares.

Voting matters and shareholder proposals

• Election of two directors: Kamil Ali-Jackson, Esq. and Ilian Iliev, Ph.D.

• Proposal to amend the Certificate of Incorporation to increase authorized common stock from 150,000,000 to 300,000,000 shares.

• Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Advisory vote on executive compensation for named executive officers.

Board of directors and corporate governance

• Board recommends voting in favor of all proposals, including director nominees and amendments.